May 2018 - DTx Pharma

DTx Pharma was named by the San Diego Venture Group as one of their 30 Cool Companies of 2018

adamdtx2019-12-26T16:45:38-08:00May 28th, 2018|

Diego, CA. DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, was named by the San Diego Venture Group (SDVG) [...]

DTx Pharma to Attend 2018 BIO International Convention

adamdtx2019-12-26T16:45:31-08:00May 16th, 2018|

San Diego, CA. DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, today announced that it will attend the 2018 [...]

DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, is pleased to announce that Jeff Friedman, MD/PhD has been appointed Chief Operating Officer, effective immediately

adamdtx2019-12-26T16:45:26-08:00May 2nd, 2018|

"Jeff is a valuable addition to the DTx Pharma team. He has served as both a scientific and business advisor since the inception of DTx [...]